Comet Therapeutics

Comet Therapeutics has been developing drugs to address previously untreatable inherited metabolic disorders. The company has developed a treatment that restores dysregulated coenzyme A metabolism through its coenzyme metabolism platform, enabling doctors to address significant unmet medical needs. Comet is eager to develop and commercialize treatments for patients with metabolic, neurological, and immune diseases.